Simple preparation of POxylated nanomaterials for cancer chemo-PDT/PTT

• Published in: European journal of pharmaceutics and biopharmaceutics Vol. 184; pp. 7 - 15
• Main Authors: Nave, Micaela, Costa, Francisco J.P., Alves, Cátia G., Lima-Sousa, Rita, Melo, Bruna L., Correia, Ilídio J., de Melo-Diogo, Duarte
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.03.2023
• Subjects: Combinatorial triple therapy; Light responsive nanoparticles; Multifunctional nanomaterials; Photodynamic therapy; Poly(2-ethyl-2-oxazoline); Polymer-IR780 conjugate; MCF-7; PEtOx-IR NPs; DLS; PTT; PDI; ANOVA; FBS; FTIR; SOSG; NHDF; DOX/PEtOx-IR NPs; CLSM; EE; PBS; PEtOx; PDT; Photodynamic therapy; Polymer-IR780 conjugate; Poly(2-ethyl-2-oxazoline); S.D; Light responsive nanoparticles; DMEM-F12; PEtOx-IR conjugate; DOX; ICG; n.s; PEG; PEtOx-SH; NIR; Combinatorial triple therapy; ROS; Multifunctional nanomaterials
• ISSN: 0939-6411; 1873-3441
• DOI: 10.1016/j.ejpb.2023.01.009

[Display omitted] Near infrared (NIR) light-responsive nanomaterials hold potential to mediate combinatorial therapies targeting several cancer hallmarks. When irradiated, these nanomaterials produce reactive oxygen species (photodynamic therapy) and/or a temperature increase (photothermal therapy). These events can damage cancer cells and trigger the release of drugs from the nanomaterials’ core. However, engineering nanomaterials for cancer chemo-photodynamic/photothermal therapy is a complex process. First, nanomaterials with photothermal capacity are synthesized, being then loaded with photosensitizers plus chemotherapeutics, and, finally functionalized with polymers for achieving suitable biological properties. To overcome this limitation, in this work, a novel straightforward approach to attain NIR light-responsive nanosystems for cancer chemo-photodynamic/photothermal therapy was established. Such was accomplished by synthesizing poly(2-ethyl-2-oxazoline)-IR780 amphiphilic conjugates, which can be assembled into nanoparticles with photodynamic/photothermal capabilities that simultaneously encapsulate Doxorubicin (DOX/PEtOx-IR NPs). The DOX/PEtOx-IR NPs presented a suitable size and surface charge for cancer-related applications. When irradiated with NIR light, the DOX/PEtOx-IR NPs produced singlet oxygen as well as a smaller thermic effect that boosted the release of DOX by 1.7-times. In the in vitro studies, the combination of DOX/PEtOx-IR NPs and NIR light could completely ablate breast cancer cells (viability ≈ 4 %), demonstrating the enhanced outcome arising from the nanomaterials’ chemo-photodynamic/photothermal therapy.